DOI QR코드

DOI QR Code

A Tubulin Inhibitor, N-(5-Benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide, Induces Anti-inflammatory Innate Immune Responses to Attenuate LPS-mediated Septic Shock

  • Park, Hyun Jung (Department of Bioscience and Biotechnology, Institute of Bioscience, Sejong University) ;
  • Lee, Sung Won (Department of Bioscience and Biotechnology, Institute of Bioscience, Sejong University) ;
  • Park, Hwangseo (Department of Bioscience and Biotechnology, Institute of Bioscience, Sejong University) ;
  • Park, Se-Ho (Department of Life Sciences, Korea University) ;
  • Hong, Seokmann (Department of Bioscience and Biotechnology, Institute of Bioscience, Sejong University)
  • Received : 2014.06.26
  • Accepted : 2014.07.31
  • Published : 2014.11.20

Abstract

The anti-inflammatory effect of a tubulin inhibitor, N-(5-benzyl-1,3-thiazol-2-yl)-3-(furan-2-yl)prop-2-enamide (1), on innate immune responses remains unclear. Thus, we investigated the effect of 1 on the immune responses mediated by lipopolysaccharide (LPS). The in vitro addition of 1 to dendritic cells and macrophages dose-dependently reduced tumor necrosis factor alpha production elicited by LPS stimulation. Additionally, the stimulation of natural killer (NK) and natural killer T (NKT) cells with 1 resulted in the decrease of interferon gamma ($IFN{\gamma}$) induced by LPS treatment. Moreover, 1 substantially reduced interleukin 12 in dendritic cells (DC) as well as $IFN{\gamma}$ in NKDCs induced by LPS in vitro. Furthermore, the in vivo administration of 1 ameliorated LPS/D-galactosamine-induced endotoxic lethality in mice. Taken together, our results demonstrate for the first time that 1 possesses anti-inflammatory properties, most notably by modulating LPS-induced innate immune responses. Therefore, 1 might have therapeutic potential for the treatment of inflammation-mediated diseases such as sepsis.

Keywords

References

  1. Gi, M.; Im, W.; Hong, S. Sensors 2009, 9, 6730. https://doi.org/10.3390/s90906730
  2. Kawai, T.; Akira, S. Int. Immunol. 2009, 21, 317. https://doi.org/10.1093/intimm/dxp017
  3. Shi, L.; Kishore, R.; McMullen, M. R.; Nagy, L. E. Am. J. Physiol. Cell Physiol. 2002, 282, C1205. https://doi.org/10.1152/ajpcell.00511.2001
  4. Abdi, K.; Singh, N. J.; Matzinger, P. J. Immunol. 2012, 188, 5981. https://doi.org/10.4049/jimmunol.1102868
  5. Varma, T. K.; Lin, C. Y.; Toliver-Kinsky, T. E.; Sherwood, E. R. Clin. Diagn. Lab. Immunol. 2002, 9, 530.
  6. Pillarisetty, V. G.; Katz, S. C.; Bleier, J. I.; Shah, A. B.; Dematteo, R. P. J. Immunol. 2005, 174, 2612. https://doi.org/10.4049/jimmunol.174.5.2612
  7. Lee, S. W.; Park, H. J.; Park, S. H.; Kim, N.; Hong, S. Biochem. Biophys. Res. Commun. 2014, 443, 413. https://doi.org/10.1016/j.bbrc.2013.11.097
  8. Cohen, J. Nature 2002, 420, 885. https://doi.org/10.1038/nature01326
  9. Stearns-Kurosawa, D. J.; Osuchowski, M. F.; Valentine, C.; Kurosawa, S.; Remick, D. G. Annu. Rev. Pathol. 2011, 6, 19. https://doi.org/10.1146/annurev-pathol-011110-130327
  10. Emoto, M. Arch. Immunol. Ther. Exp. 2003, 51, 231.
  11. Chiche, L.; Forel, J. M.; Thomas, G.; Farnarier, C.; Vely, F.; Blery, M.; Papazian, L.; Vivier, E. J. Biomed. Biotechnol. 2011, 2011, 986491.
  12. Bhattacharyya, B.; Panda, D.; Gupta, S.; Banerjee, M. Med. Res. Rev. 2008, 28, 155. https://doi.org/10.1002/med.20097
  13. Moudi, M.; Go, R.; Yien, C. Y.; Nazre, M. Int. J. Prev. Med. 2013, 4, 1231.
  14. Chan, K. S.; Koh, C. G.; Li, H. Y. Cell Death. Dis. 2012, 3, e411. https://doi.org/10.1038/cddis.2012.148
  15. Mahmoudian, M.; Rahimi-Moghaddam, P. Recent Pat. Anticancer Drug Discov. 2009, 4, 92. https://doi.org/10.2174/157489209787002524
  16. Ding, A. H.; Porteu, F.; Sanchez, E.; Nathan, C. F. J. Exp. Med. 1990, 171, 715. https://doi.org/10.1084/jem.171.3.715
  17. Rao, P.; Falk, L. A.; Dougherty, S. F.; Sawada, T.; Pluznik, D. H. J. Immunol. 1997, 159, 3531.
  18. Ben-Chetrit, E.; Bergmann, S.; Sood, R. Rheumatology 2006, 45, 274.
  19. Sugio, K.; Maruyama, M.; Tsurufuji, S.; Sharma, P. N.; Brossi, A. Life Sci. 1987, 40, 35. https://doi.org/10.1016/0024-3205(87)90249-9
  20. John, J.; Ismail, M.; Riley, C.; Askham, J.; Morgan, R.; Melcher, A.; Pandha, H. BMC Immunol. 2010, 11, 14. https://doi.org/10.1186/1471-2172-11-14
  21. Mirzapoiazova, T.; Kolosova, I. A.; Moreno, L.; Sammani, S.; Garcia, J. G.; Verin, A. D. Eur. Respir. J. 2007, 30, 429. https://doi.org/10.1183/09031936.00154206
  22. Zughaier, S.; Karna, P.; Stephens, D.; Aneja, R. PLoS One 2010, 5, e9165. https://doi.org/10.1371/journal.pone.0009165
  23. Krasavin, M.; Karapetian, R.; Konstantinov, I.; Gezentsvey, Y.; Bukhryakov, K.; Godovykh, E.; Soldatkina, O.; Lavrovsky, Y.; Sosnov, A. V.; Gakh, A. A. Arch. Pharm. 2009, 342, 420. https://doi.org/10.1002/ardp.200800201
  24. Isowa, N.; Keshavjee, S. H.; Liu, M. Am. J. Physiol. Lung Cell Mol. Physiol. 2000, 279, L1075.
  25. Wang, B.; Rao, Y. H.; Inoue, M.; Hao, R.; Lai, C. H.; Chen, D.; McDonald, S. L.; Choi, M. C.; Wang, Q.; Shinohara, M. L.; Yao, T. P. Nat. Commun. 2014, 5, 3479.
  26. Lee, S. W.; Park, H. J.; Kim, N.; Hong, S. Biomed. Res. Int. 2013, 2013, 460706.